The exploration of the TP53/RB pathway, PI3K/AKT/MTOR pathway, EGFR pathway, and other signaling pathways brought novel insights into the initiation and development of cancer and resulted in several successful targeted therapeutics. The gene discussed is EGFR; the disease is cancer.